Kohl's Corporation vs Moderna, Inc. — how do they compare? Kohl's Corporation trades at $19.24 (market cap $2.10B), while Moderna, Inc. trades at $63.62 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 11.5× Kohl's Corporation's market cap, and Kohl's Corporation pays a 2.7% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| KSS | MRNA | |
|---|---|---|
Market Cap | $2.10B | $24.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $24.71 | $81.80 |
52-Week Low | $11.72 | $22.36 |
Enterprise Value | $8.20B | $20.33B |
Dividend Yield | 2.7% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.
The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.
Trailing returns across standard periods
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →